Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)

Conditions

• Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia

Interventions

• BIOLOGICAL: humanised monoclonal antibody, veltuzumab
• BIOLOGICAL: humanised monoclonal antibody epratuzumab
• BIOLOGICAL: humanised monoclonal antibodies veltuzumab and epratuzumab

Sponsor

Queen Mary University of London

Collaborators

• [object Object]